Meditor Group’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	$6.26M	Hold	3,791,300	–	–	12.99%	2
2024 Q2	$8.42M	Hold	3,791,300	–	–	15.57%	2
2024 Q1	$10.2M	Hold	3,791,300	–	–	14.93%	2
2023 Q4	$11.3M	Hold	3,791,300	–	–	14.17%	2
2023 Q3	$3.72M	Sell	3,791,300 -611,673	-14%	-$599K	4.82%	2
2023 Q2	$6.12M	Hold	4,402,973	–	–	5.31%	2
2023 Q1	$7M	Sell	4,402,973 -65,862	-1%	-$105K	5.58%	2
2022 Q4	$27.8M	Hold	4,468,835	–	–	18.82%	2
2022 Q3	$29.9M	Hold	4,468,835	–	–	19.92%	2
2022 Q2	$28.4M	Hold	4,468,835	–	–	14.05%	2
2022 Q1	$20.7M	Hold	4,468,835	–	–	8.65%	2
2021 Q4	$22.3M	Buy	4,468,835 +1,650,000	+59%	+$8.25M	10.09%	2
2021 Q3	$34M	Hold	2,818,835	–	–	11.67%	2
2021 Q2	$59.6M	Buy	2,818,835 +139,000	+5%	+$2.94M	21.09%	2
2021 Q1	$75.2M	Hold	2,679,835	–	–	21.12%	2
2020 Q4	$69.7M	Hold	2,679,835	–	–	19.39%	2
2020 Q3	$99.6M	Hold	2,679,835	–	–	22.32%	2
2020 Q2	$138M	Hold	2,679,835	–	–	28.84%	2
2020 Q1	$68.1M	Hold	2,679,835	–	–	23.47%	2
2019 Q4	$121M	Hold	2,679,835	–	–	34.4%	2
2019 Q3	$98.2M	Hold	2,679,835	–	–	23.93%	2
2019 Q2	$125M	Hold	2,679,835	–	–	25.08%	2
2019 Q1	$108M	Hold	2,679,835	–	–	20.17%	2
2018 Q4	$123M	Buy	2,679,835 +50,000	+2%	+$2.3M	25.39%	2
2018 Q3	$117M	Hold	2,629,835	–	–	25.08%	2
2018 Q2	$103M	Buy	2,629,835 +40,600	+2%	+$1.59M	20.13%	2
2018 Q1	$187M	Buy	2,589,235 +266,400	+11%	+$19.3M	29.46%	2
2017 Q4	$153M	Buy	2,322,835 +27,900	+1%	+$1.84M	19.68%	2
2017 Q3	$115M	Buy	2,294,935 +1,728,935	+305%	+$86.7M	17.46%	2
2017 Q2	$26.2M	Buy	+566,000	New	+$26.2M	3.94%	3